NATIONAL GUIDELINES for the TREATMENT of MALARIA, SOUTH AFRICA 2018 GUIDELINES for the TREATMENT of MALARIA in SOUTH AFRICA 2018 Update
Total Page:16
File Type:pdf, Size:1020Kb
NATIONAL GUIDELINES FOR THE TREATMENT OF MALARIA, SOUTH AFRICA 2018 GUIDELINES FOR THE TREATMENT OF MALARIA IN SOUTH AFRICA 2018 update Contents Preface .................................................................................................................................................................. 4 Acknowledgements ............................................................................................................................................. 5 Abbreviations ....................................................................................................................................................... 6 Disclaimer ............................................................................................................................................................. 6 Summary ............................................................................................................................................................... 7 Approach to management ................................................................................................................................................. 7 Confirm diagnosis and assess severity ........................................................................................................................... 8 Uncomplicated malaria ...................................................................................................................................................... 9 Referral criteria .................................................................................................................................................................... 9 Severe malaria .................................................................................................................................................................. 10 1. Introduction ................................................................................................................................................. 11 2. Malaria treatment objectives ..................................................................................................................... 12 3. Parasite species .......................................................................................................................................... 12 4. Risk groups ................................................................................................................................................. 12 5. Clinical presentation and diagnosis ......................................................................................................... 13 5.1. Malaria transmission ............................................................................................................................................ 13 5.2. Symptoms and signs ............................................................................................................................................ 14 5.3. Laboratory diagnosis ............................................................................................................................................ 15 5.4. Referral criteria ...................................................................................................................................................... 17 5.5. Malaria notification ................................................................................................................................................ 17 6. Management of uncomplicated malaria ................................................................................................... 20 6.1. Uncomplicated P. falciparum malaria ................................................................................................................ 20 6.1.1. Chemotherapy ............................................................................................................................. 20 6.1.1.1. Artemether-lumefantrine ......................................................................................................... 20 6.1.1.2. Quinine ......................................................................................................................................... 23 6.1.2. General management ................................................................................................................. 24 6.1.3. Patient information for outpatient treatment ............................................................................ 24 6.2. Treatments not recommended for P. falciparum malaria ............................................................................... 26 6.3. Reducing the transmissibility of treated P. falciparum infections in areas of low intensity transmission 26 6.4. Treatment of non-falciparum infections ............................................................................................................. 27 6.5. Treatment of mixed Plasmodium species infections ....................................................................................... 29 7. Management of severe malaria ................................................................................................................. 29 7.1. WHO definition of severe malaria....................................................................................................................... 29 7.2. Management of severe malaria at the PHC level ............................................................................................ 30 7.2.1. Pre-transfer antimalarial drug treatment .................................................................................. 30 7.2.2. Pre-transfer general management............................................................................................ 30 7.3. Management of severe malaria at the hospital level ....................................................................................... 30 7.3.1. Initial clinical assessment and management .......................................................................... 31 7.3.2. Chemotherapy ............................................................................................................................. 31 7.3.2.1. Artesunate ................................................................................................................................ 31 7.3.2.2. Quinine ...................................................................................................................................... 32 7.3.3. General management ................................................................................................................. 34 7.4. Fluid management in severe malaria ................................................................................................................. 35 7.5. Management of malaria complications .............................................................................................................. 36 7.5.1. Severe malarial anaemia ........................................................................................................... 36 7.5.2. Hypoglycaemia ............................................................................................................................ 36 7.5.3. Cerebral malaria .......................................................................................................................... 37 7.5.4. Renal failure ................................................................................................................................. 37 7.5.5. Circulatory collapse ..................................................................................................................... 38 7.5.6. Metabolic acidosis ....................................................................................................................... 40 7.5.7. Respiratory distress .................................................................................................................... 41 7.5.8. Hepatic dysfunction ..................................................................................................................... 41 7.5.9. Bleeding ........................................................................................................................................ 42 7.5.10. Secondary infections ............................................................................................................... 42 7.5.11. Hyperparasitaemia .................................................................................................................. 43 7.5.12. Malarial haemoglobinuria ....................................................................................................... 43 7.5.13. Splenic rupture ......................................................................................................................... 44 8. Treatment of malaria in high-risk groups ................................................................................................ 44 8.1. Pregnancy .............................................................................................................................................................. 44 8.1.1. Diagnosis of malaria in pregnancy ........................................................................................... 44 8.1.2. Management of uncomplicated malaria in pregnancy ........................................................... 45 8.1.3. Management of severe malaria in pregnancy .......................................................................